Expert opinion on pharmacotherapy
-
Expert Opin Pharmacother · Mar 2015
Multicenter Study Observational StudyProlonged-release oxycodone/naloxone in opioid-naïve patients - subgroup analysis of a prospective observational study.
Prolonged-release oxycodone/naloxone (OXN PR) showed improved gastrointestinal tolerability and equivalent analgesic efficacy compared to oxycodone alone in patients with non-cancer pain or cancer pain. This is the first dataset to demonstrate its effectiveness and safety compared to other strong opioids in opioid-naïve patients. ⋯ The favorable outcomes under real-life conditions suggest that OXN PR provides a valuable option for treatment of moderate-to-severe pain without using weak opioids first.